10/21/2026 14:27
New TOURISE and LIONS Advisory Study Reveals How Creativity Creates a Commercial Advantage for Destination Growth

50% of travelers cannot remember the last advertisement they saw for a tourism company or destination, with a further 7% unsure Tourism faces an $11 billion marketing investment gap: restoring the category’s share of voice to 3% would require global travel and transport ad spend to reach $43.4 billion by 2027 63% of Large Language Model (LLM) visibility is driven by long-term brand equity, compared with 22% from current marketing activity and 11% from citation volume TOURISE, the world’s premier...

BioLab Holdings Launches EmeraNova™ to Advance the Future of Tissue Restoration

BioLab Holdings announced today a new, larger mission with the launch ofEmeraNova™, a new corporate identity that reflects a broader ambition to advance tissue restoration across specialties, healing phases, and care settings. The launch marks the company’s efforts to build a global platform focused on...
Anglais

Nomios Expands Presence in Southern Europe with Leading Portuguese Cybersecurity Services Specialist Orbcom

Nomios, a pan-European specialist in cybersecurity services, announces the acquisition of Orbcom, a leading Portuguese provider of cybersecurity services and IT consulting solutions with about €15 million of yearly revenue and 80 FTEs. Orbcom is one of the few partners with Diamond Innovator status within the Palo Alto Networks NextWave Partner Program in Portugal and a key partner of Netskope, Infoblox and Arista. The acquisition marks another milestone in Nomios’ European expansion, establishing the Group’s first foothold...
Anglais

illumynt Expands Ohio Operations to Support Growing Demand for Advanced Technology Lifecycle Services

illumynt,a technology-driven lifecycle management company specializing in advanced diagnostics, repair, component recovery and secure processing, today announced the expansion of its Columbus-area operations to approximately 200,000 square feet, significantly increasing the company’s capacity to support the rapidly evolving requirements of AI...
Anglais
09/23/2026 23:00
EdgeCortix Unveils RAIDEN, a Scalable, Energy-Efficient AI Chiplet Platform Purpose-Built for Physical AI

Physical AI has a system problem. Machines that perceive, reason and act in the real world cannot scale by adding AI accelerators alone. Compute, memory capacity, memory bandwidth, connectivity, and software must scale together and continue scaling as the AI models and application workloads evolve. Today, EdgeCortix®, a leading Japanese fabless semiconductor company specializing in energy-efficient AI processing, unveiled RAIDEN™, its next-generation scalable AI chiplet platform purpose-built to...

09/23/2026 23:01
HeadFirst Global Becomes Vertage, Uniting 11 Businesses in a Single Work Orchestration Platform

HeadFirst Global, a leader in work orchestration, today announced it will become Vertage, as it builds a global technology platform that dynamically curates the right mix of expert talent and AI agents to deliver the work outcomes enterprises need. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260923823506/en/Edzard Overbeek, Group CEO at Vertage The €10 billion group is bringing its 11 operating businesses together under the Vertage...

10/26/2026 11:00
Two-Year Data of Pimicotinib Demonstrated Durable Tumor Control and Sustained Improvement in TGCT Symptoms and Joint Function

Improvements in symptoms of pain, stiffness, and range of motion were sustained through two years Tumor responses remained robust 1 and durable 2 Not intended for U.K.-, U.S.- or Canada-based media Merck, a leading science and technology company, today announced new two-year follow-up results from the Phase 3 MANEUVER study evaluating pimicotinib in patients with tenosynovial giant cell tumor (TGCT). The study showed that among patients initially randomized to pimicotinib, improvements in sympto...